In an unusual move, the Federal Trade Commission is trying to block the acquisition of Dublin-based Horizon Therapeutics by US multi national Amgen, claiming it would enable the two companies to entrench a monopoly

Pascal Soriot said drugmaker initially wanted to make a $360 million investment in the UK but that the country’s tax rate was “discouraging”

The exact source of Ireland’s soaring tax take since the ending of the Double Irish is opaque, but untangling the corporate structure of Alphabet reveals how vulnerable our corporate tax boom is

It was a good year for Elon Musk, with Tesla now more valuable than almost all its auto industry rivals combined